ADA Scientific Sessions 2026 Abstract

AdoXLong Platform Applied to Semaglutide for Once-Monthly Administrations

By Audrey Marechal, Martin Gaudier, Olivier Soula, Ulysse Naessens

Experiments in animalsInterventions

The paper

Audrey Marechal, Martin Gaudier, Olivier Soula, Ulysse Naessens

Lyon

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, late-breaking 3104-LB

doi.org/10.2337/db26-3104-lb

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance